ICON will be at #EBF, 18–20 November. Visit booth B-15 to meet our bioanalytical experts and learn how we support drug development with regulatory-compliant solutions. https://ow.ly/L0x150XiU3t
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Adaptive Clinical Trial Designs Are Innovative
Article featuring commentary from Rolf Hvelmann and Parvin Fardipour on tackling the operational challenges of adaptive trials.
-
Big Changes for EU Medical and In Vitro Diagnostic Device Regulations
In this new ACT article, Vicki Anastasi share details on how medical device manufacturers will be challenged to generate clinical data on safety, performance and any undesirable side effects under newMDR and IVDR regulations.
-
CROs and Next-Gen Drug Development
An article featuring commentary from Steve Cutler on thefuture of drug development.
-
Is There A Better Way To Value Asset Duration In Biopharma Deal-Making?
ICON’s Andy Smith discusses the role of duration in the valuation of early-stage biopharma assets in this In Vivo article.
-
Time Is Money
ICON’s Andy Smith discusses the role of duration in the valuation of early-stage biopharma assets in this In Vivo article.
-
Proving Real World Value
In the July/Aug 2017 issue of PME, Ramita Tandon discusses how to usereal world intelligenceto demonstrate drug efficacy and cost-effectiveness.
-
Domestic Research Enhancement Act Changing Clinical Trials Outsourcing
This article includes commentary from Steve Cutler on US healthcare policy and its effect onclinical trial outsourcing.
-
The Burden of Choice
Dr. Martin Lachs, Dr. Reinhard Eisebitt and Dr. Valerii Fedorov contribute to this article in Clinical Oncologist Daily on ICON's decision to invest in a Cancer Moonshot project using quantum computing.
-
ICON Oncology’s Opinion of How We Can Reach for the Stars With a Moonshot
Dr. Martin Lachs, Dr. Reinhard Eisebitt and Dr. Valerii Fedorov contribute to this article in Clinical Oncologist Daily on ICON's decision to invest in a Cancer Moonshot project using quantum computing.
-
APAC is the fastest growing market for CRO industry
In this article, Mary Pan outlines the growth and trends of clinical trials in the APAC region.
